Capecitabine and streptozocin ± cisplatin for gastroenteropancreatic neuroendocrine tumours: predictors of long-term survival in the NET01 trial
Principais autores: | , , , , , , , , , , , , , , , , |
---|---|
Formato: | Conference item |
Publicado em: |
Oxford University Press
2016
|